MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma
about
Alpinumisoflavone suppresses tumour growth and metastasis of clear-cell renal cell carcinoma.Prognostic significance of microRNA-101 in solid tumor: A meta-analysis.The prognostic value of decreased miR-101 in various cancers: a meta-analysis of 12 studies.Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.
P2860
MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma
@en
MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma.
@nl
type
label
MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma
@en
MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma.
@nl
prefLabel
MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma
@en
MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma.
@nl
P2093
P2860
P1476
MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma
@en
P2093
Chong Chen
Guoqiang Bao
Haili Tang
Huadong Zhao
Jianguo Lu
P2860
P304
P577
2016-11-01T00:00:00Z